Cited by 130Protease and Inhibitor MechanismsGlioma Diagnosis and TreatmentMechanisms of cancer metastasis

Molecular determinants of glioma cell migration and invasion

Wild-Bode, Christine, Weller, Michael, Wick, Wolfgang·2001·Journal of Neurosurgery

Abstract

Object. Migration and invasion are important prerequisites for the infiltrative and destructive growth patterns of malignant gliomas. Infiltrative growth prevents complete tumor resection and causes significant neurological morbidity and mortality. Methods. The authors assessed the expression of matrix metalloproteinases (MMPs) at messenger RNA and protein levels, MMP-2 and MMP-9 activities, and expression levels of a panel of anti- and proapoptotic proteins of the BCL-2 family. They then correlated their findings with α V β 3 integrin expression and the migratory and invasive potentials in 12 human malignant glioma cell lines. Multiple MMPs were expressed by most cell lines. The levels of MMP-2 and MMP-3 and the activities of MMP-2 and MMP-9 correlated with tumor cell invasion. Migration and invasion were also correlated. Although the expression levels of α V β 3 integrin did not predict migration or invasion, a neutralizing α V β 3 integrin antibody inhibited migration and invasion selectively in cell lines that contained a high level of α V β 3 integrin expression, thus indicating the important role of α V β 3 integrin for migration and invasion in this subset of cell lines. An expression pattern of BCL-2 family proteins that favor resistance to apoptosis was associated with enhanced migration, invasion, and MMP activity. Wild-type p53 cell lines migrated farther than mutant p53 cell lines. Conclusions. Activities of MMP-2 and MMP-9 are the best predictors of glioma cell invasion. The α V β 3 integrin mediates migration and invasion in a subset of glioma cell lines, but these processes do not depend on α V β 3 integrin expression. Antiapoptotic BCL-2 family protein expression is a predictor of efficient migration and invasion.

Integrity signals

Registry

Crossref · 10.3171/jns.2001.94.6.0978

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wild-Bode, C., Weller, M., & Wick, W.
Affiliations
University of Tübingen (DE)
Venue
Journal of Neurosurgery
Published
2001-06
Volume
94
Issue
6
Pages
978-984
ISSN
0022-3085 (ISSN-L)
OpenAlex
W2087802327
Cited by
130
References
1
Citations by year
2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 2 · 2014: 7 · 2013: 10 · 2012: 10
FWCI
2.27
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of neurosurgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
glioma, tumor cell migration, tumor invasion, matrix metalloproteinases, MMP-2, MMP-9, MMP-3, alpha v beta 3 integrin, Bcl-2 family proteins, apoptosis resistance, p53, tumor infiltration, glioma cell lines
MeSH terms
Brain Neoplasms, Cell Movement, Glioma, Humans, Neoplasm Invasiveness, RNA, Messenger, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Receptors, Vitronectin, Proto-Oncogene Proteins c-bcl-2, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review